Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier’s gangrene: A case report

INTRODUCTION: Sodium glucose cotransporter-2 inhibitors (SGLT2) are an increasingly administered class of medication used to lower blood glucose levels in patients with type 2 diabetes mellitus. Diabetic ketoacidosis (DKA) and Fournier’s gangrene are rare, but potentially catastrophic side effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindsay, Patrick J., Gibson, Lauren E., Bittner, Edward A., Berg, Sheri, Chang, Marvin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695895/
https://www.ncbi.nlm.nih.gov/pubmed/33395826
http://dx.doi.org/10.1016/j.ijscr.2020.11.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695895/
https://www.ncbi.nlm.nih.gov/pubmed/33395826
http://dx.doi.org/10.1016/j.ijscr.2020.11.037

Ejemplares similares